Doxorubicin Completed Phase 1 Trials for Myelodysplastic/Myeloproliferative Diseases / Myelodysplastic Syndromes (MDS) / Malignant Lymphomas / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00003243Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer